FASLG and systemic lupus erythematosus: Over-expression of membrane-bound Fas ligand (CD95L) exacerbated autoimmune disease and renal pathology in pristane-induced lupus [43], and administering anti-FasL monoclonal antibody to an NZB/W F1 mouse model of lupus prevented the development of lupus nephritis [44].